A recent review took a look at the promise of measuring circulating tumor DNA (ctDNA) with digital-droplet PCR (ddPCR) in pancreatic ductal adenocarcinoma (PDAC) as the landscape of this cancer continues to shift toward personalized, precision treatment.
There are many sources, and definitions, of where the value in cancer care lies. In this panel discussion, a cancer survivor and patient advocate, an oncologist, and a benefits professional provided their perspectives on what value in cancer care means to them.
COVID-19 led many patients to change their use of disease-modifying antirheumatic drugs in the pandemic’s initial months, with or without physician guidance.
A 2021 survey on health care trends to monitor finds provider burnout, disengagement, and shortage of health care professionals as the most potentially disruptive issues facing hospitals and health systems in the next 3 years.
Polymerase chain reaction testing of suspected cases of adenoviral conjunctivitis in a hospital setting resulted in large cost savings by avoiding unnecessary employee furloughs.
Lalan Wilfong, MD, executive vice president, Value Based Care & Quality Programs, Texas Oncology, and cochair, Payment Reform, Community Oncology Alliance, speaks on the evolution of remote monitoring in cancer care and how value-based oncology may look in the near future.
Edward Licitra, MD, PhD, medical oncologist, Astera Health Partners, discusses his thoughts on what value-based cancer care entails and how physicians can best align their goals with those of the patient and health plan.
A machine learning model using the gut microbiome may serve as a successful predictive measure for type 2 diabetes development.
Veterans Affairs data show that among patients with heart failure admitted to skilled nursing facilities, those with delirium exhibited decreased rates of functional recovery.
Approximately 45% of patients with obstructive sleep apnea were shown to present with nonalcoholic fatty liver disease, with age and weight indicated as significant predictors of high fibrosis score risk.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The CDC updates its guidelines on cleaning surfaces; 2020 saw a 6% decrease in suicide rates; racial COVID-19 disparities reported in Montana.
This week, the top managed care news included a European safety committee finding very rare blood clot links with AstraZeneca’s COVID-19 vaccine; new report predicts shifts in the cancer landscape by 2040; the connected nature of type 1 diabetes with other autoimmune diseases.
Research published in November found an 85% drop in breast cancer screening and a 75% drop in colon cancer screening. Since that time, screening rates have improved somewhat.
Patients who experienced a fall within 12 months of multiple myeloma (MM) treatment initiation had a shorter median survival compared to those without falls.
Patients who cut their calorie intake by at least 10% and exercised modestly were 70% less likely to have remaining leukemic cells in their bone marrow 1 month after starting chemotherapy, according to results of an early study.
The study also indicated that the type of transplantation donor impacted outcomes following the procedure.
A popular misconception of palliative care is that it only has importance toward making patients comfortable at the end of their lives, noted a palliative care physician on the first day of the 2021 Community Oncology Conference, presented by the Community Oncology Alliance.
A multidimesional rehabilitation program characterized by cognitive, physical, occupational, and speech therapies was found to improve functional and cognitive abilities in people with mild to moderate Parkinson disease.
Kathy Oubre, MS, chief operating officer of Pontchartrain Cancer Center, discusses cost-saving implications of biosimilars in oncology, as well as several barriers that continue to impede their use.
Ted Okon, MBA, executive director of the Community Oncology Alliance, discusses what influence the new administration may have on payment reform in oncology and issues regarding the 340B drug pricing program.
Day 1 of this year’s virtual Community Oncology Conference opened with a panel discussion that touched on all things related to the COVID-19 pandemic, with leaders presenting a unified front.
A meta-analysis, where many studies ranged in evidence quality, revealed mixed results on the effectiveness of blended self-management interventions in chronic lung conditions, establishing a need for more research.
Officials urge the Biden administration to track COVID-19 deaths among health care workers; the B.1.1.7 variant is now the dominant strain in the United States; pandemic results in steep declines in STD testing.
Jeff Patton, MD, CEO, OneOncology, and chairman of the board, Tennessee Oncology, discusses what influence COVID-19 will have on discussions at the Community Oncology Conference 2021, as well as takeaways he hopes audience members and participants gain from the conference.
A higher risk of adult-onset heart failure was found in this Swedish study that investigated its association with singleton live births before 37 weeks gestation.
Because health literacy can have different meanings for patients with different diseases, this review aimed to crystalize a definition in patients with multiple sclerosis (MS) and emphasize its importance in care planning.
More information will come from 4-year results, which will be critical to assess whether there is any long-term benefit to visual acuity using aflibercept.
Cases of pancreatic and liver cancers are expected to rise by 2040, and there will be more melanoma cases, according to new estimates of future US cancer incidence and death.
University of Oxford pauses AstraZeneca COVID-19 vaccine study in children; psychiatric, neurological illness rates high in patients who’ve had COVID-19; new CDC reports shows possible link between multisystem inflammatory syndrome and asymptomatic COVID-19.
